Hims(US:HIMS) Finbold·2025-06-03 13:15Core Viewpoint - Hims & Hers Health is strategically expanding into Europe through the acquisition of ZAVA, a leading digital health platform, which has positively impacted its stock price and reflects investor optimism [1][3][5] Financial Performance - Hims & Hers reported a 111% year-over-year revenue growth in Q1 2025, reaching $586 million, with a net income of $49.5 million [3] - The company's subscriber base expanded by 38%, totaling nearly 2.4 million users [3] Market Expansion - The acquisition of ZAVA will allow Hims & Hers to expand its services into Germany, France, Ireland, and strengthen its presence in the United Kingdom [3][5] - The stock rose 7.77% in pre-market trading on June 3, 2025, indicating strong investor confidence in the company's growth strategy [1][3] Strategic Focus - Despite regulatory challenges, Hims & Hers is diversifying its portfolio by focusing on personalized healthcare solutions and exploring new treatment categories such as low testosterone and menopause [4]